Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction have?
Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction has 16 citations in the OpenAlex counts ScholarIQ stores.
When was Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction published?
Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction has 2019 year in the ScholarIQ index.
What is the open-access status of Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction?
Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction has hybrid oa status in the ScholarIQ index.
What is the DOI of Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction?
The DOI for Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction is on the source record.
What is the PMID of Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction?
The PMID for Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction is on the source record.
What is the OpenAlex record for Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction?
The OpenAlex for Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction is on the source record.